Linden Advisors’s Liminatus Pharma, Inc. Warrants LIMNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$56.3K Buy
+268,199
New +$56.3K ﹤0.01% 336